OTC · Financial Statements

Aoxing Pharmaceutical Company, Inc. (AOXG) Financial Statements

$0.00 OTC: AOXG Market Cap $266756

Aoxing Pharmaceutical Company, Inc. most recently reported annual revenue of $0, net profit of $0. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20242025
Revenue$0$0
Operating Profit$0$0
Net Profit$0$0
EPS$0.00$0.00
Op Margin——

Balance Sheet (USD)

Metric20242025
Total Assets——
Total Liabilities——
Cash——
Borrowings$0$0

Cash Flow (USD)

Metric20242025
Operating Cash Flow$0—
Investing Cash Flow$0—
Financing Cash Flow$0—
Net Cash Flow$0—
Free Cash Flow$0$0

Valuation & Return Ratios

MetricValue
PEG Ratio-0.87
EV / EBITDA-22.55
FCF Yield-39.43%
Quick Ratio0.96
Interest Coverage0.00
Return 1Y-46.97%
Return 3Y66.67%
Return 5Y-66.98%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
AOXG Overview AOXG Dividend Run Stock Screener